Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 1/20 | 0.50 |
| ▸ | MAP3K14 | Q99558 | 2/20 | 0.49 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.49 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | JAK3 | P52333 | 1/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.41 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.38 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24309679 | 0.83 | CLK1 (0.48) | FGFR1ADORA1LCKKDRJAK3 | |
| SCHEMBL3425059 | 0.81 | ADORA2A (0.56) | FGFR1MAP3K14GRM4ADORA1LCK | |
| SCHEMBL3021383 | 0.78 | ADORA1 (0.59) | GRM4ADORA1ADORA2A | |
| SCHEMBL4200127 | 0.74 | FGFR1 (0.71) | FGFR1ADORA1LCKKDRJAK3 | |
| SCHEMBL21121007 | 0.74 | KMT2A (0.47) | MAP3K14GRM4ADORA1LCKKDR | |
| SCHEMBL10936938 | 0.73 | ADORA1 (0.58) | MAP3K14GRM4ADORA1MAPK14ADORA2A | |
| SCHEMBL3366260 | 0.73 | MAP3K14 (0.50) | MAP3K14GRM4ADORA1LCKKDR | |
| SCHEMBL7147816 | 0.73 | ADORA2A (0.52) | ADORA1KDM4EALDH1A1POLBADORA2A | |
| SCHEMBL29539989 | 0.73 | CYP2A6 (0.57) | ADORA1KDM4EALDH1A1ADORA2A | |
| SCHEMBL2916502 | 0.72 | FGFR1 (0.50) | FGFR1GRM4ADORA1LCKKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022076627-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |